Hers review
Hers (Hims & Hers Health, NYSE: HIMS) now sells only FDA-approved branded GLP-1 medications for weight loss — Wegovy, Zepbound, Ozempic, Mounjaro, and the new orforglipron pill 'Foundayo' — rather than compounded semaglutide.
- Semaglutide
- $348/mo (brand Wegovy, plus a separate fee)
- Tirzepatide
- $448/mo (brand Zepbound, plus a separate fee)
- Coverage
- All 50 states
- Brand-name
- Yes
Semaglutide · modeled / year
$4,176
Tirzepatide · modeled / year
$5,376
Pricing verified August 2026
The Index scorecard
Hers scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Sells only FDA-approved branded medications (Wegovy, Zepbound, Ozempic, Mounjaro) rather than compounded versions
- Multiple formats per drug (pill vs pen/vial), including a newer pill option and microdosing plan
- Large, publicly traded parent (Hims & Hers Health) with an established clinical/support infrastructure
The tradeoffs
- The advertised 'From $X/mo' price is medication-only — a mandatory membership fee ($39 first month, then $149/mo, billed separately) is layered on top and roughly doubles the real steady-state monthly cost
- No compounded, lower-cost semaglutide/tirzepatide option was found on the current site
- The membership fee 'does not include or guarantee a prescription,' so it can recur even in a month without a fresh prescription
- FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025; the letter is public in FDA's warning-letter database
The bottom line
Best for: Cost-first shoppers who want brand-name FDA-approved GLP-1 access with a mainstream telehealth name. Hers (Hims & Hers Health, NYSE: HIMS) now sells only FDA-approved branded GLP-1 medications for weight loss — Wegovy, Zepbound, Ozempic, Mounjaro, and the new orforglipron pill 'Foundayo' — rather than compounded semaglutide.
Ranked #279 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Hers.
- #259VitaFusions IV— VitaFusions IV is a Dallas, TX-based IV-therapy and medical-weight-loss provider that does genuinely sell compounded semaglutide ($149/mo) and tirzepatide ($189/mo) at a flat, dose-independent monthly rate with no memberships or contracts.60/100
- #260YourHealthRx— YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network.60/100
- #261VevaRX— VevaRX sells compounded semaglutide at $189 a month and tirzepatide only as a $467 quarterly plan with a three-month minimum, on a site that prints at least eight mutually contradictory prices for its own products.60/100
- #262Collective— Collective sells compounded semaglutide at $59 and tirzepatide at $69 a month, both genuinely medication prices, on top of a $199 annual membership that is required, auto-renewing and not refundable.57/100
- #263Fifty 410— Fifty 410 is a direct-to-consumer compounded-GLP-1 telehealth service.59/100
- #264Bliv— Bliv is a telehealth provider selling personalized compounded GLP-1 programs.59/100
The 24 programs nearest this one
- #280 MaxLife58
- #281 Alloy58
- #282 BloomWell Rx58
- #283 Coby Health58
- #284 Coivas58
- #285 Elara MD58
- #286 EOS Health58
- #287 Human+58
- #288 Lean Rx58
- #289 MedLeanRx58
- #290 Näky58
- #291 Neo Soma Healthcare58
- #292 Sumbare Wellness58
- #293 Transparent Meds58
- #294 Trinity Meds58
- #295 Lttl55
- #296 24hrDOC57
- #297 HealthOn57
- #298 Tuyo Health57
- #299 Ascend Medical57
- #300 Center for Medical Weight Loss (CMWL)57
- #301 Concierge MD LA57
- #302 DreamHug Medical57
- #303 Emerge Weight Loss57
Pricing, states and verification reflect Hers's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Hers's site. Not medical advice; see our disclosure.